HIV therapy Flashcards

(25 cards)

1
Q

What are NRTIs?

A

Nucleoside Reverse Transcriptase Inhibitors

Examples: AZT (zidovudine), ddI (didanosine), ddC (zalcitabine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the mechanism of NRTIs?

A

Chain terminators → inhibit reverse transcription

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is AZT known for?

A

First FDA-approved HIV drug (1987)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How are NRTIs used in therapy?

A

Used in combination therapy to prevent resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are NNRTIs?

A

Non-Nucleoside Reverse Transcriptase Inhibitors

Examples: Nevirapine, Efavirenz, Etravirine, Doravirine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the mechanism of NNRTIs?

A

Bind reverse transcriptase, block activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are Protease Inhibitors (PIs)?

A

Drugs that prevent viral maturation by blocking protease

Examples: Saquinavir, Darunavir

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the side effects of Protease Inhibitors?

A

Lipodystrophy (fat redistribution)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are Entry Inhibitors?

A

Drugs that prevent viral entry

Examples: Maraviroc (CCR5 antagonist), Enfuvirtide (fusion inhibitor)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is a challenge of Entry Inhibitors?

A

Expensive, requires injections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are Integrase Inhibitors?

A

Drugs that prevent integration of viral DNA into host genome

Examples: Raltegravir, Dolutegravir, Elvitegravir

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is HAART?

A

Highly Active Antiretroviral Therapy

Combines 3 drugs (e.g., 2 NRTIs + 1 NNRTI/PI)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the effectiveness of HAART?

A

Reduces viral load 99% in 8 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are challenges associated with HAART?

A

Side effects, cost, resistance, compliance issues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is Pre-Exposure Prophylaxis (PrEP)?

A

Truvada (tenofovir + emtricitabine) taken daily or on-demand before exposure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the effectiveness of PrEP?

A

90% effective in preventing HIV

17
Q

What is Post-Exposure Prophylaxis (PEP)?

A

Truvada + Raltegravir, must be taken within 72 hours of exposure

18
Q

What are challenges in HIV vaccine development?

A

Unclear protective immunity, high genetic variability, trial complexity, ethical issues

19
Q

What was the AIDSVAX trial?

A

Targeted gp120, Phase III trial failed

20
Q

What was the RV144 trial?

A

Prime-boost strategy (Canarypox + AIDSVAX), 31% infection reduction

21
Q

What are some recent notable vaccine trials?

A

Uhambo, Imbokodo, Mosaico all failed

22
Q

What are Broadly Neutralizing Antibodies (bnAbs)?

A

Target conserved regions of HIV Env protein

23
Q

What is the goal of bnAbs?

A

Induce bnAb production via vaccines or passive immunization

24
Q

What are challenges with bnAbs?

A

Glycan shield, sequence variability, trimer instability

25
What are key takeaways from HIV research?
HAART revolutionized HIV treatment, PrEP & PEP reduce infection risk, vaccine development faces hurdles, bnAbs offer hope for future treatments